1. Home
  2. KROS vs SKYT Comparison

KROS vs SKYT Comparison

Compare KROS & SKYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • SKYT
  • Stock Information
  • Founded
  • KROS 2015
  • SKYT 1991
  • Country
  • KROS United States
  • SKYT United States
  • Employees
  • KROS N/A
  • SKYT N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • SKYT Semiconductors
  • Sector
  • KROS Health Care
  • SKYT Technology
  • Exchange
  • KROS Nasdaq
  • SKYT Nasdaq
  • Market Cap
  • KROS 565.0M
  • SKYT 578.1M
  • IPO Year
  • KROS 2020
  • SKYT 2021
  • Fundamental
  • Price
  • KROS $15.65
  • SKYT $9.84
  • Analyst Decision
  • KROS Buy
  • SKYT Strong Buy
  • Analyst Count
  • KROS 14
  • SKYT 3
  • Target Price
  • KROS $20.56
  • SKYT $12.67
  • AVG Volume (30 Days)
  • KROS 445.6K
  • SKYT 1.1M
  • Earning Date
  • KROS 11-05-2025
  • SKYT 11-06-2025
  • Dividend Yield
  • KROS N/A
  • SKYT N/A
  • EPS Growth
  • KROS N/A
  • SKYT N/A
  • EPS
  • KROS 0.47
  • SKYT N/A
  • Revenue
  • KROS $232,844,000.00
  • SKYT $289,663,000.00
  • Revenue This Year
  • KROS $5,579.44
  • SKYT $24.47
  • Revenue Next Year
  • KROS N/A
  • SKYT $44.03
  • P/E Ratio
  • KROS $33.59
  • SKYT N/A
  • Revenue Growth
  • KROS 85820.30
  • SKYT N/A
  • 52 Week Low
  • KROS $9.12
  • SKYT $5.67
  • 52 Week High
  • KROS $72.37
  • SKYT $19.00
  • Technical
  • Relative Strength Index (RSI)
  • KROS 59.98
  • SKYT 41.40
  • Support Level
  • KROS $15.25
  • SKYT $10.16
  • Resistance Level
  • KROS $16.00
  • SKYT $11.43
  • Average True Range (ATR)
  • KROS 0.61
  • SKYT 0.74
  • MACD
  • KROS 0.03
  • SKYT -0.24
  • Stochastic Oscillator
  • KROS 78.77
  • SKYT 10.00

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About SKYT SkyWater Technology Inc.

SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.

Share on Social Networks: